People with inflammatory bowel disease (IBD) like Crohn's or ulcerative colitis may need immunosuppressive biologic therapy to control the disease. Some of these drugs can cross the placenta and many pregnant women worry about the effect this may have on the baby. But multiple studies have found no link between using biologic agents and adverse pregnancy outcomes.
Dr. Sunanda Kane, M.D., goes further to explain a recent study, which found that the effectiveness of vaccines given to infants does not appear to be affected by exposure to biologic therapy taken by mothers with IBD during pregnancy. The study was published in Clinical Gastroenterology and Hepatology.
For more information about IBD, visit mayoclinic.org/IBD
Dr. Kane is a gastroenterologist at Mayo Clinic.
Meet others talking about inflammatory bowel diseases (IBD) like Crohn's and ulcerative colitis on Mayo Clinic Connect – an online community where you can share experiences, ask questions, and find support from people like you.
Liked by Teresa, Volunteer Mentor
Send an email to invite people you know to join the Gastroenterology & GI Surgery page.